{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T09:38:37Z","timestamp":1772357917283,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N006364\/2"],"award-info":[{"award-number":["MR\/N006364\/2"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V033417\/1"],"award-info":[{"award-number":["MR\/V033417\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000737","name":"University of Exeter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022854","name":"European Cystic Fibrosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jcf.2023.10.017","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T09:38:08Z","timestamp":1699004288000},"page":"354-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPA"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2016-833X","authenticated-orcid":false,"given":"Jacob D.","family":"Bradbury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1028-4927","authenticated-orcid":false,"given":"Emily","family":"Chesshyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-2757","authenticated-orcid":false,"given":"Annalisa","family":"Orenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-6691","authenticated-orcid":false,"given":"Andreas","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6586-3358","authenticated-orcid":false,"given":"Adilia","family":"Warris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2023.10.017_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/jof7121067","article-title":"A visual and comprehensive review on COVID-19-associated pulmonary aspergillosis (CAPA)","volume":"7","author":"Feys","year":"2021","journal-title":"J. Fungi"},{"key":"10.1016\/j.jcf.2023.10.017_bib0002","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jcf.2023.10.017_bib0003","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill COVID19 patients. A multinational observational study by the European confederation of medical mycology","volume":"28","author":"Prattes","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcf.2023.10.017_bib0004","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmi.2022.01.027","article-title":"Defining COVID-19\u2013associated pulmonary aspergillosis: systematic review and meta-analysis","volume":"28","author":"Kariyawasam","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcf.2023.10.017_bib0005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcf.2021.03.017","article-title":"Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020","volume":"20","author":"Naehrlich","year":"2021","journal-title":"J. Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2023.10.017_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/23120541.00411-2021","article-title":"Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe","volume":"7","author":"Jung","year":"2021","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.jcf.2023.10.017_bib0007","doi-asserted-by":"crossref","first-page":"e98502","DOI":"10.1371\/journal.pone.0098502","article-title":"Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis","volume":"9","author":"Armstead","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2023.10.017_bib0008","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1164\/rccm.200603-423OC","article-title":"Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis 2006","volume":"11","author":"Kraemer","year":"2006","journal-title":"Am. J. Resp. Crit. Care Med."},{"key":"10.1016\/j.jcf.2023.10.017_bib0009","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1034\/j.1399-3003.2000.016003464.x","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study","volume":"16","author":"Mastella","year":"2000","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jcf.2023.10.017_bib0010","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/archdischild-2016-311132","article-title":"Effect of allergic bronchopulmonary aspergillosis on FEV 1 in children and adolescents with cystic fibrosis: a European cystic fibrosis society patient registry analysis","volume":"102","author":"Kaditis","year":"2017","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jcf.2023.10.017_bib0011","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1164\/rccm.201908-1585OC","article-title":"Aspergillus infections and progression of structural lung disease in children with cystic fibrosis","volume":"201","author":"Breuer","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jcf.2023.10.017_bib0012","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcf.2019.08.008","article-title":"The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis","volume":"19","author":"Hong","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2023.10.017_bib0013","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/thoraxjnl-2018-211550","article-title":"Aspergillus and progression of lung disease in children with cystic fibrosis","volume":"74","author":"Harun","year":"2019","journal-title":"ThoraxThorax"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2023.10.017_bib0014","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jcf.2010.08.018","article-title":"The European cystic fibrosis patient registry: the power of sharing data","volume":"9","author":"Sheppard","year":"2010","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2023.10.017_bib0015","unstructured":"Orenti A., Zolin A., Jung A., van Rens et\u00a0al. ECFS patient registry 2020 annual data report 2022. Last accessed on 28.2.23 from https:\/\/www.ecfs.eu\/projects\/ecfs-patient-registry\/annual-reports."},{"key":"10.1016\/j.jcf.2023.10.017_bib0016","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/cid\/ciac333","article-title":"Cumulative incidence and risk factors for severe coronavirus disease 2019 in French people with cystic fibrosis","volume":"75","author":"Corvol","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcf.2023.10.017_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcf.2020.11.021","article-title":"Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: an international observational study","volume":"20","author":"Bain","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2023.10.017_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.06.006","article-title":"Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: a global observational study","volume":"21","author":"Carr","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2023.10.017_bib0019","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s15010-021-01737-z","article-title":"Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian cystic fibrosis society","volume":"50","author":"Colombo","year":"2022","journal-title":"InfectionInfection"},{"key":"10.1016\/j.jcf.2023.10.017_bib0020","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jcf.2020.10.003","article-title":"The global impact of SARS-CoV-2 in 181 people with cystic fibrosis","volume":"19","author":"McClenaghan","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2023.10.017_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2022.958658","article-title":"Risk factors for severe COVID-19 in people with cystic fibrosis: a systematic review","volume":"10","author":"Terlizzi","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.jcf.2023.10.017_bib0022","first-page":"1","article-title":"The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis","volume":"6","author":"Starke","year":"2021","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.jcf.2023.10.017_bib0023","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0098-2022","article-title":"Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe","volume":"31","author":"Vardavas","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jcf.2023.10.017_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7189\/jogh.11.10001","article-title":"Risk factors for poor outcomes in hospitalised COVID-19 patients: a systematic review and meta-analysis","volume":"11","author":"Li","year":"2021","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.jcf.2023.10.017_bib0025","unstructured":"Sokhi S., Charman S., Carr S., Clarke S. UK Cystic Fibrosis Registry 2021 Annual data report 2020. Last accessed 28.2.23 from https:\/\/www.cysticfibrosis.org.uk\/the-work-we-do\/uk-cf-registry\/reporting-and-resources."},{"issue":"7","key":"10.1016\/j.jcf.2023.10.017_bib0026","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cmi.2019.11.019","article-title":"High-volume culture and quantitative -time PCR for the detection of Aspergillus in sputum","volume":"26","author":"Vergidis","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcf.2023.10.017_bib0027","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ppul.21240","article-title":"Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis","volume":"45","author":"Jubin","year":"2010","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jcf.2023.10.017_bib0028","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jcf.2018.01.008","article-title":"Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis","volume":"17","author":"Hong","year":"2018","journal-title":"J. Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2023.10.017_bib0029","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcf.2023.10.017_bib0030","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1177\/08850666211047166","article-title":"Practice guidelines for the diagnosis of COVID-19-associated pulmonary aspergillosis in an intensive care setting","volume":"37","author":"Hashim","year":"2021","journal-title":"J. Intensive Care Med."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323016661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323016661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:23:12Z","timestamp":1772353392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323016661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1569199323016661"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.10.017","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPA","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}